Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Total Liabilities (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Total Liabilities of $1.99 billion in the quarter ended Jun 30, 2026, up 2.8% from $1.94 billion a year earlier but down 8.5% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Total Liabilities (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories reported Total Liabilities of $2.12 billion, up 16.2% from the prior year.

  • Annual Total Liabilities has increased for three straight years, with a five-year compound annual growth rate of 10.9% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Total Liabilities came in at $1.83 billion in the year ended Mar 31, 2025 (+42.1%), $1.28 billion in the year ended Mar 31, 2024 (+16.6%), $1.1 billion in the year ended Mar 31, 2023 (-18.4%) and $1.35 billion in the year ended Mar 31, 2022 (+6.7%).
  • Quarterly Total Liabilities has ranged from $1.06 billion in the quarter ended Sep 30, 2022 to $2.18 billion in the quarter ended Mar 31, 2026 over the past five years.
  • On a year-over-year basis, Total Liabilities has increased for 12 consecutive quarters, with growth averaging 29.2% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 64.6% in the quarter ended Sep 30, 2024, against a decline of 22.0% in the quarter ended Jun 30, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.18 billion (quarter ended Mar 31, 2026), $2.1 billion (quarter ended Dec 31, 2025) and $2.06 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 1.99 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.99 Bn
Mar 31, 2026 2.18 Bn
Dec 31, 2025 2.10 Bn
Sep 30, 2025 2.06 Bn
Jun 30, 2025 1.94 Bn
Mar 31, 2025 1.80 Bn
Dec 31, 2024 1.89 Bn
Sep 30, 2024 1.87 Bn
Jun 30, 2024 1.45 Bn
Mar 31, 2024 1.29 Bn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 1.14 Bn
Jun 30, 2023 1.09 Bn
Mar 31, 2023 1.11 Bn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 1.06 Bn
Jun 30, 2022 1.40 Bn
Mar 31, 2022 1.36 Bn
Dec 31, 2021 1.23 Bn
Sep 30, 2021 1.28 Bn
API Access

Dr Reddys Laboratories Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEY